Balanced news tone
News Sentiment
PACS sentiment intelligence
PACS Group, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-2.8% over one week, +19.1% over four weeks, trend active, and materially above fair value.
PACS (NYSE: PACS) holder to sell 15,827,237 shares on NYSE
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
PACS (NYSE: PACS) holder to sell 15,827,237 shares on NYSE
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 15 Jul 2026 22:18
- Source
- Stock Titan
PACS (NYSE: PACS) investor plans sale of 10,296 common shares
A Form 144 notice indicates that Mark Hancock, an investor in PACS Group, Inc. (NYSE: PACS), intends to sell 10,296 shares of common stock through Citigroup Global Markets Inc. The planned sale has an aggregate market value of $463,680.36, with an approximate sale date of July 14
- Tone
- Negative 41/100
- Event
- Market update
- Published
- 14 Jul 2026 21:11
- Source
- Stock Titan
PACS or ALHC: Which Is the Better Value Stock Right Now?
This article evaluates PACS Group, Inc. (PACS) and Alignment Healthcare (ALHC) as potential value stock opportunities in the Medical Services sector. Using the Zacks Rank and Style Scores, particularly the Value category, the analysis concludes that PACS presents a better value,
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 14 Jul 2026 14:40
- Source
- Yahoo! Finance Canada
Lawsuit alleges PACS Group hid Medicare fraud, misleading investors since 2020.
A lawsuit has been filed against PACS Group, Inc., accusing the company of Medicare fraud from 2020 to 2023, claiming these fraudulent billings constituted all of its operating and net income. The lawsuit alleges PACS Group submitted false Medicare claims, billed for unnecessary
- Tone
- Negative 28/100
- Event
- Regulatory and legal
- Published
- 14 Jul 2026 14:10
- Source
- Pluang
NYSE: PACS ALERT: Investors in shares of PACS Group, Inc. shares should contact the Shareholders Foundation in connection with Lawsuit
The Shareholders Foundation, Inc. is advising investors in PACS Group, Inc. (NYSE: PACS) who purchased shares prior to April 2024 and still hold them, to contact them regarding a pending lawsuit. The lawsuit alleges that PACS Group engaged in a scheme to submit false Medicare cla
- Tone
- Negative 20/100
- Event
- Regulatory and legal
- Published
- 14 Jul 2026 14:10
- Source
- PR Newswire
Health care facilities: Value-based care reshapes sector financials (PACS:NYSE)
The healthcare facilities sector is undergoing a significant transformation due to the shift towards value-based care and increased flexibility in site-of-care. This change is impacting the financial models of companies, moving away from volume-based reimbursements to outcome-bas
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 13 Jul 2026 18:40
- Source
- Seeking Alpha
PACS Group: I Like The Fundamentals, But Valuation Is Not Cheap (NYSE:PACS)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 08:19
- Source
- Seeking Alpha
Discipline and Rules-Based Execution in PACS Response
This article analyzes Pacs Group Inc. (NASDAQ: PACS) highlighting a weak near-term sentiment that could shift mid and long-term outlooks. It identifies a significant risk-reward short setup and provides detailed institutional trading strategies including position, momentum, and r
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 20:11
- Source
- Stock Traders Daily
PACS Group: The Facility Maturation Playbook Works, But It's Already Priced In (NYSE:PACS)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 13:38
- Source
- Seeking Alpha
PACS group director Mark Hancock sells $1.14m in stock
Mark Hancock, a director and ten percent owner of PACS Group, Inc. (NASDAQ:PACS), recently sold shares totaling approximately $1.14 million through a Rule 10b5-1 trading plan. These sales occurred on July 8 and 9, 2026, with weighted average prices around $45.06 per share, while
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 22:40
- Source
- Investing.com
PACS group director Mark Hancock sells $1.14m in stock By Investing.com
Mark Hancock, a director and ten percent owner of PACS Group, Inc. (NASDAQ:PACS), recently sold shares of the company’s common stock totaling approximately $1.14 million. These sales, conducted under a Rule 10b5-1 trading plan, occurred on July 8 and 9, 2026, with prices ranging
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 10 Jul 2026 22:39
- Source
- Investing.com Nigeria
Mark Hancock sells large PACS blocks (PACS) — trades via Citigroup
Mark Hancock has reported multiple sales of PACS Group, Inc. common stock between June 15, 2026, and July 8, 2026, as detailed in a Form 144 SEC filing. These transactions, facilitated by Citigroup Global Markets Inc., include significant sales of 153,254 shares for over $5.5 mil
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 23:10
- Source
- Stock Titan
Utah group acquires several SA medical facilities
Pacs Group, based in Salt Lake City, is acquiring 34 Eduro Healthcare facilities, with more than half a dozen of these located in the San Antonio (Alamo City) region. This transaction marks a significant medical deal involving the Utah group and indicates a focus on expansion wit
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Jul 2026 09:43
- Source
- The Business Journals
PACS (NYSE) Form 144: Holder Mark Hancock reports multiple sales
A recent Form 144 filing for PACS Group, Inc. (NYSE) indicates that holder Mark Hancock has reported multiple sales of common shares between June 15, 2026, and July 6, 2026. The filing also notes an issuer-origin acquisition of over 54 million shares on March 1, 2023. These trans
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 20:39
- Source
- Stock Titan
PACS Group (NYSE:PACS) Stock Forecast & Analyst Predictions
PACS Group is forecast to grow earnings by 16.6% and revenue by 7.5% annually. The average analyst price target has recently been increased to $49.17, indicating a 34% upside from the current trading price. Recent news highlights include the acquisition of 34 skilled nursing faci
- Tone
- Positive 59/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 20:10
- Source
- Simply Wall Street
How Removal From Key Russell Value Indexes Will Impact PACS Group (PACS) Investors
PACS Group, Inc. was removed from key Russell Value benchmarks in late June 2026, which is expected to prompt adjustments by index-tracking funds. This change primarily affects the stock's ownership and trading dynamics rather than its underlying business drivers. Investors are n
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 07:10
- Source
- Simply Wall Street
PACS Group (NASDAQ: PACS) CAO sells 15,000 shares under 10b5-1 plan
PACS Group's Chief Accounting Officer, Michelle Renee Lewis, reported selling 15,000 shares of common stock in three open-market transactions at a weighted average price around $45 per share. These sales were executed according to a pre-arranged Rule 10b5-1 trading plan adopted o
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 07 Jul 2026 07:10
- Source
- Stock Titan
PACS Group CAO Michelle Lewis sells $675k in company stock
Michelle Lewis, Chief Accounting Officer of PACS Group, Inc. (NASDAQ:PACS), sold 15,000 shares of company stock for over $675,000 in early July 2026 under a pre-arranged trading plan. These sales occurred as PACS stock traded near its 52-week high, having gained 242% in the past
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 23:40
- Source
- Investing.com
Insider Mark Hancock trims PACS Group, Inc. (PACS) stake
PACS Group director Mark Hancock sold a total of 161,068 shares of common stock across three transactions between July 1 and July 6, 2026, for approximately $7.30 million. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan. Additionally, Hancock received 4,2
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 22:40
- Source
- Stock Titan
Director at PACS Group (PACS) awarded 4,287 RSUs vesting by 2027
PACS Group, Inc. director Patrick Hugh Conway received an equity award of 4,287 restricted stock units (RSUs), with no purchase price. These RSUs will convert into one share of Common Stock each upon vesting. The vesting condition requires Conway's continued service to the compan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 22:40
- Source
- Stock Titan
Director Taylor Leavitt awarded 4,287 RSUs at PACS Group (PACS)
PACS Group, Inc. director Taylor S. Leavitt was granted 4,287 restricted stock units (RSUs) with a vesting date on the earlier of July 1, 2027, or the next annual meeting, provided he remains in service. This award, valued at $0.00 per share, increases his direct holdings to 19,7
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 22:40
- Source
- Stock Titan
Mark Hancock sells PACS shares (NYSE: PACS) in multiple Form 144 filings
Mark Hancock has reported multiple proposed sales of common stock in PACS Group, Inc. (NYSE: PACS) through Form 144 filings. These filings detail transactions on several dates in June and July 2026, showing the number of shares sold and the gross proceeds for each sale. The trans
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 02 Jul 2026 20:09
- Source
- Stock Titan
Have Insiders Sold PACS Group Shares Recently?
A recent analysis of PACS Group (NYSE: PACS) insider transactions revealed that the Chief Accounting Officer sold US$600k worth of shares, and the Chief Legal Officer sold US$4.8m in the last year, both at prices below the current market value. While significant insider ownership
- Tone
- Negative 36/100
- Event
- Market update
- Published
- 02 Jul 2026 16:29
- Source
- Simply Wall Street
Why Is PACS Group Stock Soaring Tuesday?
PACS Group, Inc. (NYSE: PACS) stock increased over 7% on Tuesday following the announcement of its plan to acquire the operations of 34 skilled nursing facilities from Eduro Healthcare, significantly expanding its post-acute care portfolio. This acquisition includes 3,633 skilled
- Tone
- Positive 74/100
- Event
- Deals and strategy
- Published
- 02 Jul 2026 06:40
- Source
- Sahm
Lawsuit UPDATE: Investors who hold PACS Group, Inc. (NYSE: PACS) shares should contact the Shareholders Foundation
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 29 Jun 2026 14:25
- Source
- Newswire.com
PACS Group(PACS.US) 10% Shareholder Sells US$8.08 Million in Common Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Moomoo
PACS Group's (NYSE:PACS) Performance Is Even Better Than Its Earnings Suggest
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 May 2026 11:07
- Source
- Simply Wall St.
PACS Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
Assessing PACS Group (PACS) Valuation After Q1 Earnings Beat And New US$250 Million Buyback
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Market source
PACS Group: Strong Comeback That’s Backed By Improving Fundamentals (NYSE:PACS)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Seeking Alpha